• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PHAT

PHAT

Phathom Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD10.09

+0.44 (+4.56%)

Rating:C

Company Profile

CEO

Steven L. Basta

IPO Date

2019-10-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$9.63

Prev. Close

$9.65

Day Low

$9.53

Day High

$10.22

52W Low

$4.47

52W High

$18.31

Market Cap

$0.80B

Volume

1.99M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.8%

Avg Negative

2.8%

Avg Neutral

66.4%

News Feed

Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/25/2021·↑ positive

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

GlobeNewsWire·5/11/2021·↑ positive

Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

GlobeNewsWire·5/6/2021·↑ positive

Phantom Pharmaceuticals Could See Substantial Upside With 2 Upcoming Phase 3 Readouts

Seeking Alpha·4/7/2021·↑ positive

Why Mustang Bio, Phathom Pharma And More Are Moving Today

Benzinga·2/2/2021·↑ positive

Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

GlobeNewsWire·1/19/2021·↑ positive

Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team

Business Wire·1/7/2021·↑ positive

Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock

GlobeNewsWire·12/16/2020·↑ positive

Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock

GlobeNewsWire·12/15/2020·↑ positive

Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)

GlobeNewsWire·12/14/2020·↑ positive